Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,702,987
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
23,819,490
-
Shares change
-
+3,322,757
-
Total reported value, excl. options
-
$336,535,131
-
Value change
-
+$49,552,065
-
Put/Call ratio
-
85%
-
Number of buys
-
58
-
Number of sells
-
-34
-
Price
-
$14.13
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q1 2021
121 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q1 2021.
Altimmune, Inc. - Common Stock (ALT) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23,819,490 shares
of 80,702,987 outstanding shares and own 29.52% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (3,500,000 shares), STATE STREET CORP (2,942,179 shares), BAKER BROS. ADVISORS LP (2,758,518 shares), Capital World Investors (1,404,000 shares), VANGUARD GROUP INC (1,327,210 shares), D. E. Shaw & Co., Inc. (1,315,814 shares), CITADEL ADVISORS LLC (1,130,259 shares), CAAS CAPITAL MANAGEMENT LP (1,106,529 shares), BlackRock Inc. (1,058,187 shares), and CREDIT SUISSE AG/ (914,439 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.